Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro Device Group is a Polish neuro-medtech company focused on devices for neuroscience research, diagnosis, rehabilitation, and therapy of central nervous system disorders. The company develops non-invasive brain stimulation technologies based on transcranial electrical stimulation, including tDCS, tES, tACS, and tRNS-enabled systems. Its named products include nurostym tES, a medical-device-certified brain stimulator, and Neuro Device Voic, a clinical-stage system for rehabilitation of aphasia and related speech disorders. Neuro Device Group also distributes selected research and medical technologies in areas such as eye tracking, rehabilitation, virtual reality, and functional MRI. Overall, the business appears centered on neurostimulation-enabled therapeutic and diagnostic tools rather than conventional drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro Device Group.